 Megan Kelsey
Concepts (277)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 34 | 2023 | 2167 | 4.640 |
Why?
| | Insulin Resistance | 16 | 2023 | 1174 | 3.750 |
Why?
| | Puberty | 10 | 2022 | 147 | 3.700 |
Why?
| | Pediatric Obesity | 12 | 2021 | 515 | 3.460 |
Why?
| | Hypoglycemic Agents | 8 | 2022 | 1033 | 2.060 |
Why?
| | Bariatric Surgery | 7 | 2022 | 167 | 1.600 |
Why?
| | Obesity, Morbid | 8 | 2022 | 202 | 1.570 |
Why?
| | Metformin | 6 | 2021 | 301 | 1.490 |
Why?
| | Obesity | 16 | 2023 | 2802 | 1.450 |
Why?
| | Adolescent | 54 | 2023 | 19126 | 1.420 |
Why?
| | Prediabetic State | 6 | 2021 | 228 | 1.380 |
Why?
| | Body Mass Index | 14 | 2022 | 2174 | 1.230 |
Why?
| | Insulin-Secreting Cells | 3 | 2021 | 325 | 1.140 |
Why?
| | Testosterone | 6 | 2022 | 371 | 1.040 |
Why?
| | Adolescent Behavior | 3 | 2020 | 502 | 1.020 |
Why?
| | Health Behavior | 3 | 2020 | 745 | 0.970 |
Why?
| | Child | 39 | 2022 | 19282 | 0.940 |
Why?
| | Hypothalamic Neoplasms | 1 | 2022 | 10 | 0.870 |
Why?
| | Blood Glucose | 12 | 2021 | 1949 | 0.870 |
Why?
| | Hypothalamic Diseases | 1 | 2022 | 18 | 0.870 |
Why?
| | Body Composition | 4 | 2021 | 721 | 0.830 |
Why?
| | Cardiovascular Diseases | 7 | 2023 | 1812 | 0.770 |
Why?
| | Menstruation Disturbances | 1 | 2018 | 12 | 0.680 |
Why?
| | Insulin | 6 | 2021 | 2156 | 0.670 |
Why?
| | Polycystic Ovary Syndrome | 4 | 2021 | 159 | 0.660 |
Why?
| | Gonadal Steroid Hormones | 1 | 2019 | 123 | 0.660 |
Why?
| | Female | 48 | 2023 | 63903 | 0.640 |
Why?
| | Adipose Tissue | 3 | 2021 | 632 | 0.630 |
Why?
| | Transgender Persons | 1 | 2020 | 126 | 0.630 |
Why?
| | Humans | 65 | 2023 | 121869 | 0.610 |
Why?
| | Male | 41 | 2023 | 60475 | 0.590 |
Why?
| | Clinical Trials as Topic | 1 | 2021 | 1012 | 0.580 |
Why?
| | Glucose Tolerance Test | 6 | 2021 | 367 | 0.560 |
Why?
| | Body Weight | 1 | 2020 | 1001 | 0.550 |
Why?
| | Diabetes Mellitus, Type 1 | 3 | 2022 | 3347 | 0.520 |
Why?
| | Sex Factors | 4 | 2019 | 1898 | 0.490 |
Why?
| | Brain Neoplasms | 1 | 2022 | 1031 | 0.480 |
Why?
| | Cross-Sectional Studies | 10 | 2021 | 4713 | 0.480 |
Why?
| | Leptin | 1 | 2015 | 232 | 0.470 |
Why?
| | Muscle Fatigue | 1 | 2014 | 93 | 0.470 |
Why?
| | Task Performance and Analysis | 1 | 2014 | 171 | 0.460 |
Why?
| | Thinness | 1 | 2013 | 96 | 0.450 |
Why?
| | Mass Screening | 3 | 2022 | 1089 | 0.450 |
Why?
| | Disease Progression | 1 | 2020 | 2582 | 0.440 |
Why?
| | Off-Label Use | 2 | 2022 | 48 | 0.410 |
Why?
| | Depression | 2 | 2023 | 1201 | 0.400 |
Why?
| | Biomarkers | 4 | 2020 | 3652 | 0.400 |
Why?
| | Cohort Studies | 8 | 2021 | 5300 | 0.380 |
Why?
| | Life Style | 4 | 2021 | 436 | 0.370 |
Why?
| | Metabolic Syndrome | 4 | 2020 | 393 | 0.350 |
Why?
| | Androgens | 2 | 2022 | 175 | 0.350 |
Why?
| | Sex Hormone-Binding Globulin | 2 | 2019 | 54 | 0.350 |
Why?
| | Muscle, Skeletal | 3 | 2014 | 1553 | 0.340 |
Why?
| | Reference Values | 2 | 2020 | 804 | 0.330 |
Why?
| | Ribonuclease III | 2 | 2021 | 39 | 0.320 |
Why?
| | Estradiol | 3 | 2022 | 485 | 0.320 |
Why?
| | Weight Gain | 2 | 2022 | 520 | 0.310 |
Why?
| | DEAD-box RNA Helicases | 2 | 2021 | 59 | 0.310 |
Why?
| | Bone Density | 2 | 2023 | 477 | 0.310 |
Why?
| | Case-Control Studies | 6 | 2021 | 3314 | 0.290 |
Why?
| | Pituitary Neoplasms | 2 | 2021 | 164 | 0.290 |
Why?
| | Fructosamine | 2 | 2016 | 21 | 0.280 |
Why?
| | Deoxyglucose | 2 | 2016 | 50 | 0.280 |
Why?
| | Diabetes, Gestational | 2 | 2023 | 272 | 0.280 |
Why?
| | Germ-Line Mutation | 3 | 2021 | 134 | 0.280 |
Why?
| | Serum Albumin | 2 | 2016 | 149 | 0.270 |
Why?
| | Young Adult | 10 | 2023 | 11223 | 0.260 |
Why?
| | Risk Factors | 7 | 2023 | 9419 | 0.260 |
Why?
| | Follow-Up Studies | 7 | 2023 | 4883 | 0.250 |
Why?
| | Radius | 2 | 2023 | 30 | 0.250 |
Why?
| | Gastrointestinal Microbiome | 2 | 2021 | 532 | 0.240 |
Why?
| | Age Factors | 3 | 2021 | 3173 | 0.240 |
Why?
| | Hypoglycemia | 2 | 2019 | 401 | 0.240 |
Why?
| | Glucose Clamp Technique | 2 | 2015 | 195 | 0.240 |
Why?
| | Aging | 1 | 2014 | 1692 | 0.240 |
Why?
| | Hydrodynamics | 1 | 2023 | 33 | 0.240 |
Why?
| | Longitudinal Studies | 3 | 2023 | 2652 | 0.220 |
Why?
| | Population Health | 1 | 2023 | 47 | 0.220 |
Why?
| | Colorado | 4 | 2020 | 4344 | 0.210 |
Why?
| | Bariatrics | 1 | 2021 | 5 | 0.210 |
Why?
| | Obesity Management | 1 | 2021 | 7 | 0.210 |
Why?
| | Blast Crisis | 1 | 2021 | 19 | 0.200 |
Why?
| | Sleep | 2 | 2018 | 794 | 0.200 |
Why?
| | Overnutrition | 1 | 2021 | 40 | 0.200 |
Why?
| | Anti-Obesity Agents | 1 | 2021 | 48 | 0.200 |
Why?
| | Hypertension | 2 | 2021 | 1241 | 0.200 |
Why?
| | Hypogonadism | 1 | 2010 | 79 | 0.190 |
Why?
| | Iatrogenic Disease | 1 | 2020 | 52 | 0.190 |
Why?
| | Hyperinsulinism | 1 | 2021 | 108 | 0.190 |
Why?
| | Treatment Outcome | 6 | 2021 | 9654 | 0.190 |
Why?
| | Gastric Bypass | 1 | 2021 | 93 | 0.190 |
Why?
| | Diabetic Ketoacidosis | 1 | 2022 | 170 | 0.190 |
Why?
| | Bone and Bones | 1 | 2023 | 302 | 0.190 |
Why?
| | Prognosis | 4 | 2021 | 3603 | 0.180 |
Why?
| | ACTH-Secreting Pituitary Adenoma | 1 | 2009 | 7 | 0.180 |
Why?
| | Cushing Syndrome | 1 | 2009 | 9 | 0.180 |
Why?
| | Adult | 11 | 2022 | 32683 | 0.180 |
Why?
| | Klinefelter Syndrome | 1 | 2020 | 51 | 0.180 |
Why?
| | Hospitals, Pediatric | 2 | 2022 | 500 | 0.180 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 81 | 0.180 |
Why?
| | Pseudohypoaldosteronism | 1 | 2009 | 2 | 0.180 |
Why?
| | Sexual Maturation | 1 | 2019 | 51 | 0.180 |
Why?
| | Growth Hormone | 1 | 2019 | 111 | 0.180 |
Why?
| | Capillaries | 1 | 2019 | 104 | 0.180 |
Why?
| | Linear Models | 2 | 2019 | 886 | 0.180 |
Why?
| | Gastrectomy | 1 | 2020 | 84 | 0.180 |
Why?
| | Prospective Studies | 5 | 2021 | 6629 | 0.180 |
Why?
| | Vascular Malformations | 1 | 2019 | 46 | 0.170 |
Why?
| | Dyslipidemias | 1 | 2021 | 164 | 0.170 |
Why?
| | Drug Administration Schedule | 1 | 2021 | 770 | 0.170 |
Why?
| | Oligonucleotides, Antisense | 1 | 2009 | 104 | 0.170 |
Why?
| | Hyperkalemia | 1 | 2009 | 29 | 0.170 |
Why?
| | Reproductive Health | 1 | 2019 | 77 | 0.170 |
Why?
| | Exercise | 3 | 2023 | 1866 | 0.170 |
Why?
| | Research | 1 | 2022 | 446 | 0.170 |
Why?
| | Double-Blind Method | 2 | 2021 | 1720 | 0.170 |
Why?
| | Drug Therapy, Combination | 2 | 2019 | 1003 | 0.170 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 104 | 0.170 |
Why?
| | Time Factors | 3 | 2021 | 6889 | 0.170 |
Why?
| | Fatty Liver | 1 | 2021 | 250 | 0.160 |
Why?
| | Analysis of Variance | 2 | 2019 | 1383 | 0.160 |
Why?
| | Psychotherapy, Group | 1 | 2018 | 69 | 0.160 |
Why?
| | Risk Reduction Behavior | 1 | 2020 | 212 | 0.160 |
Why?
| | Aspartate Aminotransferases | 1 | 2018 | 101 | 0.160 |
Why?
| | Exome | 1 | 2019 | 226 | 0.160 |
Why?
| | Diet | 2 | 2017 | 1164 | 0.160 |
Why?
| | Adenoma | 1 | 2009 | 190 | 0.160 |
Why?
| | Overweight | 1 | 2022 | 544 | 0.150 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2009 | 346 | 0.150 |
Why?
| | Academic Medical Centers | 1 | 2019 | 416 | 0.150 |
Why?
| | Depressive Disorder | 1 | 2020 | 367 | 0.150 |
Why?
| | Human Development | 1 | 2016 | 20 | 0.150 |
Why?
| | Adiposity | 1 | 2021 | 505 | 0.150 |
Why?
| | Biodiversity | 1 | 2020 | 383 | 0.140 |
Why?
| | Retrospective Studies | 6 | 2022 | 13063 | 0.140 |
Why?
| | United States | 8 | 2022 | 13209 | 0.140 |
Why?
| | Diabetic Nephropathies | 1 | 2019 | 289 | 0.140 |
Why?
| | Hyperglycemia | 2 | 2016 | 325 | 0.140 |
Why?
| | Hydrocortisone | 1 | 2018 | 333 | 0.140 |
Why?
| | Triglycerides | 2 | 2020 | 523 | 0.140 |
Why?
| | Infant | 5 | 2021 | 8440 | 0.140 |
Why?
| | Child, Preschool | 5 | 2022 | 9776 | 0.140 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2021 | 486 | 0.130 |
Why?
| | Pilot Projects | 1 | 2020 | 1472 | 0.130 |
Why?
| | Adiponectin | 1 | 2016 | 231 | 0.130 |
Why?
| | Neoplasms, Complex and Mixed | 1 | 2014 | 8 | 0.130 |
Why?
| | Infant, Newborn | 3 | 2020 | 5336 | 0.130 |
Why?
| | Sex Characteristics | 1 | 2019 | 700 | 0.130 |
Why?
| | Algorithms | 1 | 2022 | 1618 | 0.120 |
Why?
| | Risk | 1 | 2017 | 925 | 0.120 |
Why?
| | Bacteria | 1 | 2020 | 764 | 0.120 |
Why?
| | Lipolysis | 1 | 2013 | 46 | 0.120 |
Why?
| | Observer Variation | 1 | 2014 | 316 | 0.120 |
Why?
| | Nervous System Physiological Phenomena | 1 | 2013 | 23 | 0.120 |
Why?
| | Fasting | 1 | 2014 | 279 | 0.110 |
Why?
| | Adolescent Health Services | 1 | 2013 | 67 | 0.110 |
Why?
| | Nutrition Policy | 1 | 2013 | 60 | 0.110 |
Why?
| | Nutrition Assessment | 1 | 2013 | 77 | 0.110 |
Why?
| | Fatty Acids, Nonesterified | 1 | 2013 | 177 | 0.110 |
Why?
| | Feeding Behavior | 1 | 2018 | 625 | 0.110 |
Why?
| | Pediatrics | 1 | 2020 | 1002 | 0.110 |
Why?
| | Electromyography | 1 | 2014 | 345 | 0.110 |
Why?
| | Gene-Environment Interaction | 1 | 2014 | 201 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2020 | 960 | 0.110 |
Why?
| | Polyendocrinopathies, Autoimmune | 1 | 2011 | 17 | 0.110 |
Why?
| | Physical Fitness | 1 | 2013 | 189 | 0.100 |
Why?
| | Biomechanical Phenomena | 1 | 2014 | 689 | 0.100 |
Why?
| | Mutation | 3 | 2019 | 3520 | 0.100 |
Why?
| | Muscle Contraction | 1 | 2014 | 427 | 0.100 |
Why?
| | Weight Loss | 3 | 2021 | 736 | 0.100 |
Why?
| | Potassium Channels | 1 | 2011 | 136 | 0.100 |
Why?
| | Absorptiometry, Photon | 2 | 2023 | 246 | 0.100 |
Why?
| | Blood Glucose Self-Monitoring | 1 | 2014 | 510 | 0.100 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2014 | 272 | 0.100 |
Why?
| | Genome-Wide Association Study | 3 | 2023 | 1355 | 0.090 |
Why?
| | Tibia | 2 | 2023 | 179 | 0.090 |
Why?
| | Patient Education as Topic | 1 | 2015 | 720 | 0.090 |
Why?
| | Postoperative Complications | 1 | 2021 | 2322 | 0.090 |
Why?
| | Pregnancy | 4 | 2023 | 5663 | 0.090 |
Why?
| | Motor Activity | 1 | 2013 | 705 | 0.080 |
Why?
| | Randomized Controlled Trials as Topic | 2 | 2023 | 1254 | 0.070 |
Why?
| | Glycation End Products, Advanced | 2 | 2016 | 70 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2023 | 2107 | 0.060 |
Why?
| | Stomach Neoplasms | 1 | 2004 | 69 | 0.060 |
Why?
| | Anisotropy | 1 | 2023 | 73 | 0.060 |
Why?
| | Genetic Predisposition to Disease | 3 | 2021 | 2377 | 0.060 |
Why?
| | Cadherins | 1 | 2004 | 189 | 0.060 |
Why?
| | Motion | 1 | 2023 | 97 | 0.060 |
Why?
| | Comorbidity | 2 | 2021 | 1633 | 0.050 |
Why?
| | Genetic Testing | 1 | 2004 | 409 | 0.050 |
Why?
| | KCNQ1 Potassium Channel | 1 | 2021 | 4 | 0.050 |
Why?
| | Receptor, Melanocortin, Type 4 | 1 | 2021 | 11 | 0.050 |
Why?
| | Bacteroidetes | 1 | 2021 | 24 | 0.050 |
Why?
| | Nutrition Disorders | 1 | 2021 | 23 | 0.050 |
Why?
| | Transferrin | 1 | 2021 | 41 | 0.050 |
Why?
| | Animals | 3 | 2019 | 34134 | 0.050 |
Why?
| | Firmicutes | 1 | 2021 | 20 | 0.050 |
Why?
| | Intra-Abdominal Fat | 1 | 2021 | 94 | 0.050 |
Why?
| | Remission Induction | 1 | 2021 | 255 | 0.050 |
Why?
| | Polymicrogyria | 1 | 2019 | 6 | 0.050 |
Why?
| | Waist Circumference | 1 | 2020 | 136 | 0.050 |
Why?
| | Neoplasms | 1 | 2014 | 2241 | 0.050 |
Why?
| | Mice, Obese | 1 | 2009 | 61 | 0.050 |
Why?
| | Fludrocortisone | 1 | 2009 | 3 | 0.050 |
Why?
| | Mineralocorticoids | 1 | 2009 | 3 | 0.050 |
Why?
| | Precision Medicine | 1 | 2023 | 354 | 0.040 |
Why?
| | Epithelial Sodium Channels | 1 | 2009 | 12 | 0.040 |
Why?
| | Renin | 1 | 2009 | 37 | 0.040 |
Why?
| | Citrates | 1 | 2009 | 49 | 0.040 |
Why?
| | Aldosterone | 1 | 2009 | 46 | 0.040 |
Why?
| | Heart | 1 | 2023 | 671 | 0.040 |
Why?
| | Dissection | 1 | 2009 | 55 | 0.040 |
Why?
| | Craniotomy | 1 | 2009 | 71 | 0.040 |
Why?
| | DNA Mutational Analysis | 2 | 2014 | 399 | 0.040 |
Why?
| | Pedigree | 2 | 2014 | 502 | 0.040 |
Why?
| | Vitamin D Deficiency | 1 | 2021 | 170 | 0.040 |
Why?
| | Pituitary Gland | 1 | 2009 | 161 | 0.040 |
Why?
| | Potassium | 1 | 2009 | 151 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 526 | 0.040 |
Why?
| | Feces | 1 | 2021 | 400 | 0.040 |
Why?
| | Sodium Chloride | 1 | 2009 | 153 | 0.040 |
Why?
| | Gene Frequency | 1 | 2019 | 526 | 0.040 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2020 | 574 | 0.040 |
Why?
| | Qualitative Research | 1 | 2022 | 891 | 0.040 |
Why?
| | Genotype | 1 | 2023 | 1952 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2021 | 490 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 1008 | 0.040 |
Why?
| | Hospitals | 1 | 2021 | 598 | 0.040 |
Why?
| | Blotting, Western | 1 | 2009 | 1226 | 0.040 |
Why?
| | Glomerular Filtration Rate | 1 | 2019 | 641 | 0.040 |
Why?
| | Referral and Consultation | 1 | 2021 | 680 | 0.040 |
Why?
| | Survival Rate | 1 | 2021 | 1828 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 2 | 2021 | 3240 | 0.040 |
Why?
| | Area Under Curve | 1 | 2016 | 308 | 0.040 |
Why?
| | Monitoring, Ambulatory | 1 | 2016 | 86 | 0.030 |
Why?
| | Electrocardiography | 1 | 2009 | 641 | 0.030 |
Why?
| | Decision Support Techniques | 1 | 2019 | 394 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2009 | 465 | 0.030 |
Why?
| | C-Peptide | 1 | 2015 | 137 | 0.030 |
Why?
| | Surveys and Questionnaires | 2 | 2020 | 4922 | 0.030 |
Why?
| | Family Health | 1 | 2015 | 206 | 0.030 |
Why?
| | Incidence | 1 | 2021 | 2520 | 0.030 |
Why?
| | Prevalence | 1 | 2021 | 2444 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1316 | 0.030 |
Why?
| | Fatal Outcome | 1 | 2014 | 298 | 0.030 |
Why?
| | Radiography, Thoracic | 1 | 2014 | 172 | 0.030 |
Why?
| | RNA | 1 | 2009 | 860 | 0.030 |
Why?
| | Mice | 2 | 2019 | 15621 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2019 | 2727 | 0.030 |
Why?
| | Anthropometry | 1 | 2013 | 207 | 0.030 |
Why?
| | Fruit | 1 | 2013 | 130 | 0.030 |
Why?
| | Vegetables | 1 | 2013 | 133 | 0.030 |
Why?
| | Nutrition Surveys | 1 | 2013 | 229 | 0.030 |
Why?
| | Self Concept | 1 | 2013 | 224 | 0.030 |
Why?
| | Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 82 | 0.030 |
Why?
| | Liver | 1 | 2009 | 1834 | 0.020 |
Why?
| | Syndrome | 1 | 2011 | 365 | 0.020 |
Why?
| | Rituximab | 1 | 2011 | 158 | 0.020 |
Why?
| | Dietary Fats | 1 | 2013 | 339 | 0.020 |
Why?
| | Middle Aged | 3 | 2021 | 28961 | 0.020 |
Why?
| | Quality of Life | 1 | 2021 | 2453 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1738 | 0.020 |
Why?
| | Energy Intake | 1 | 2013 | 494 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2009 | 5054 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2011 | 229 | 0.020 |
Why?
| | Psychometrics | 1 | 2013 | 700 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 2999 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 1965 | 0.020 |
Why?
| | Brain | 1 | 2019 | 2693 | 0.020 |
Why?
| | Parents | 1 | 2015 | 1255 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2013 | 2876 | 0.020 |
Why?
| | Lung Diseases | 1 | 2011 | 759 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2014 | 2519 | 0.020 |
Why?
| | Autoantibodies | 1 | 2011 | 1333 | 0.020 |
Why?
| | Mutation, Missense | 1 | 2004 | 309 | 0.010 |
Why?
| | Genetic Variation | 1 | 2004 | 961 | 0.010 |
Why?
| | Aged | 1 | 2004 | 20705 | 0.000 |
Why?
|
|
Kelsey's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|